Overview Financials News + Filings Key Docs Ownership
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
|
|
RedHill Biopharma Ltd. (RDHL)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/13/2023 |
F-3
| Form F-3 - Registration statement by foreign private issuers: |
| 10/12/2023 |
D
| Form D - Notice of Exempt Offering of Securities: |
| 10/10/2023 |
6-K
| Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]: |
| 10/03/2023 |
6-K
| Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]: |
| 09/29/2023 |
6-K
| Quarterly results |
| 08/17/2023 |
6-K
| Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:|
Docs:
|
"6-K",
"Net Revenues for the six months ended June 30, 2023, were $5.4 million, as compared to $31.5 million for the six months ended June 30, 2022. The decrease was primarily attributable to the divestiture of Movantik, resulting in the discontinuation of revenue recognition from this product starting from February 2, 2023. Talicia net revenues for the six months ended June 30, 2023, were $5.1 million, as compared to $4 million for the six months ended June 30, 2022, primarily due to an increase of 10% in units sold. Cost of Revenues for the six months ended June 30, 2023, was $2.4 million, as compared to $15.3 million for the six months ended June 30, 2022. This decrease was primarily attributable to the divestiture of Movantik. As a result of this divestiture, both the recognition of revenues a...",
"CONDENSED CONSOLIDATED INTERIM FINANCIAL INFORMATION" |
|
| 08/14/2023 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 08/11/2023 |
424B3
| Form 424B3 - Prospectus [Rule 424(b)(3)]: |
| 08/09/2023 |
6-K
| Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]: |
| 08/08/2023 |
6-K
| Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]: |
| 08/07/2023 |
D
| Form D - Notice of Exempt Offering of Securities: |
| 08/04/2023 |
F-3
| Form F-3 - Registration statement by foreign private issuers: |
| 08/01/2023 |
6-K
| Quarterly results |
| 07/31/2023 |
6-K
| Quarterly results |
| 07/25/2023 |
6-K
| Quarterly results |
| 07/25/2023 |
424B3
| Form 424B3 - Prospectus [Rule 424(b)(3)]: |
| 07/25/2023 |
424B3
| Form 424B3 - Prospectus [Rule 424(b)(3)]: |
| 07/25/2023 |
6-K
| Quarterly results |
| 07/25/2023 |
424B5
| Form 424B5 - Prospectus [Rule 424(b)(5)]: |
| 07/21/2023 |
6-K
| Quarterly results |
| 07/21/2023 |
6-K
| Quarterly results |
| 07/06/2023 |
6-K
| Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]: |
| 06/29/2023 |
S-8
| Form S-8 - Securities to be offered to employees in employee benefit plans: |
| 06/29/2023 |
6-K
| Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]: |
| 06/12/2023 |
6-K
| Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]: |
| 05/09/2023 |
6-K
| Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]: |
| 05/04/2023 |
6-K
| Quarterly results |
| 05/01/2023 |
6-K
| Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]: |
| 04/28/2023 |
20-F
| Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]: |
| 04/28/2023 |
6-K
| Quarterly results |
| 04/21/2023 |
6-K
| Quarterly results |
| 04/03/2023 |
6-K
| Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]: |
| 04/03/2023 |
6-K
| Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:|
Docs:
|
"6-K",
"ARTICLE I.",
"The Holder and any assignee, by acceptance of this Warrant, acknowledge and agree that, by reason of the provisions of this paragraph, following the purchase of a portion of the Warrant ADSs hereunder, the number of Warrant ADSs available for purchase hereunder at any given time may be less than the amount stated on the face hereof.",
"The Holder and any assignee, by acceptance of this Warrant, acknowledge and agree that, by reason of the provisions of this paragraph, following the purchase of a portion of the Warrant ADSs hereunder, the number of Warrant ADSs available for purchase hereunder at any given time may be less than the amount stated on the face hereof.",
"The Holder and any assignee, by acceptance of this Warrant, acknowledge and agree that, by reason of the provisions of this paragraph, following the purchase of a portion of the Warrant ADSs hereunder, the number of Warrant ADSs available for purchase hereunder at any given time may be less than the amount stated on the face hereof.",
"The Holder and any assignee, by acceptance of this Warrant, acknowledge and agree that, by reason of the provisions of this paragraph, following the purchase of a portion of the Warrant ADSs hereunder, the number of Warrant ADSs available for purchase hereunder at any given time may be less than the amount stated on the face hereof.",
"Tel Aviv, Israel 6473921" |
|
| 04/03/2023 |
424B5
| Form 424B5 - Prospectus [Rule 424(b)(5)]: |
|
|
|